Ben Tre Pharmaceutical JSC (HOSE:DBT)
12,300
-50 (-0.40%)
At close: Feb 21, 2025
HOSE:DBT Cash Flow Statement
Financials in millions VND. Fiscal year is January - December.
Millions VND. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2019 | FY 2018 | FY 2017 | 2016 - 2012 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | 2016 - 2012 |
Net Income | 15,275 | 16,195 | 21,396 | 20,193 | 28,737 | Upgrade
|
Depreciation & Amortization | 17,121 | 8,884 | 13,336 | 13,007 | 11,778 | Upgrade
|
Loss (Gain) From Sale of Assets | -4,001 | 4,054 | - | - | -29,404 | Upgrade
|
Other Operating Activities | -7,598 | -1,440 | -7,223 | -4,208 | -2,363 | Upgrade
|
Change in Accounts Receivable | 125,668 | -12,200 | 11,450 | -44,032 | 14,561 | Upgrade
|
Change in Inventory | -108,854 | 65,536 | -104,463 | 18,380 | 7,526 | Upgrade
|
Change in Accounts Payable | -127,567 | -84,186 | -9,390 | 914.59 | 5,104 | Upgrade
|
Change in Other Net Operating Assets | 5,795 | 3,518 | 776.47 | -15,069 | 15,135 | Upgrade
|
Operating Cash Flow | -84,160 | 361.64 | -74,118 | -10,814 | 51,072 | Upgrade
|
Operating Cash Flow Growth | - | - | - | - | 56.16% | Upgrade
|
Capital Expenditures | -34,002 | -7,318 | -6,822 | -10,513 | -9,016 | Upgrade
|
Sale of Property, Plant & Equipment | - | 2,126 | - | 7,534 | 14,932 | Upgrade
|
Investment in Securities | -57,543 | -60,186 | -28,148 | 2,557 | -31,676 | Upgrade
|
Other Investing Activities | 3,606 | 2,812 | 6,570 | 8,519 | 7,175 | Upgrade
|
Investing Cash Flow | -67,239 | -62,566 | -42,400 | 8,097 | -53,129 | Upgrade
|
Short-Term Debt Issued | - | - | - | - | 572,220 | Upgrade
|
Long-Term Debt Issued | 974,330 | 782,262 | 697,476 | 538,385 | - | Upgrade
|
Total Debt Issued | 974,330 | 782,262 | 697,476 | 538,385 | 572,220 | Upgrade
|
Short-Term Debt Repaid | - | - | - | - | -564,853 | Upgrade
|
Long-Term Debt Repaid | -616,942 | -719,327 | -592,327 | -537,279 | - | Upgrade
|
Total Debt Repaid | -616,942 | -719,327 | -592,327 | -537,279 | -564,853 | Upgrade
|
Net Debt Issued (Repaid) | 357,388 | 62,935 | 105,148 | 1,106 | 7,367 | Upgrade
|
Issuance of Common Stock | 19,062 | 7,000 | 12,143 | - | 34,598 | Upgrade
|
Repurchase of Common Stock | - | - | -97.85 | - | - | Upgrade
|
Common Dividends Paid | - | - | -13,529 | -18,343 | -12,276 | Upgrade
|
Other Financing Activities | -237,842 | - | - | - | - | Upgrade
|
Financing Cash Flow | 138,608 | 69,935 | 103,665 | -17,237 | 29,689 | Upgrade
|
Foreign Exchange Rate Adjustments | 6.49 | 23.19 | - | - | - | Upgrade
|
Net Cash Flow | -12,785 | 7,754 | -12,853 | -19,954 | 27,633 | Upgrade
|
Free Cash Flow | -118,162 | -6,956 | -80,940 | -21,328 | 42,056 | Upgrade
|
Free Cash Flow Growth | - | - | - | - | 49.08% | Upgrade
|
Free Cash Flow Margin | -13.61% | -0.86% | -10.11% | -2.63% | 5.26% | Upgrade
|
Free Cash Flow Per Share | -5755.41 | - | - | - | 2613.12 | Upgrade
|
Cash Interest Paid | 42,276 | 39,419 | 15,165 | 14,031 | 11,178 | Upgrade
|
Cash Income Tax Paid | 10,687 | 1,915 | 3,736 | 3,117 | 8,026 | Upgrade
|
Levered Free Cash Flow | -55,578 | - | -87,108 | 3,759 | -34,583 | Upgrade
|
Unlevered Free Cash Flow | -30,510 | - | -77,618 | 12,015 | -27,597 | Upgrade
|
Change in Net Working Capital | 44,415 | - | 102,641 | 7,536 | 49,800 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.